PROPHYLACTIC AND THERAPEUTIC NUTRITIONAL SUPPLEMENT FOR CREATION/MAINTENANCE OF HEALTH-PROTECTIVE INTESTINAL MICROFLORA AND ENHANCEMENT OF THE IMMUNE SYSTEM

Abstract: The present invention relates to nutritive compositions containing whey, FOS, and bovine or caprine colostrum for the creation and maintenance of a healthy intestinal flora and for the enhancement of the immune system.

Description: PROPHYLACΗC AND THERAPEUTIC NUTRIΗONAL SUPPLEMENT FOR CREAΗON/MAINTENANCE OF HEALTH-PROTECTIVE INTESTINAL MICROFLORA AND ENHANCEMENT OF THE IMMUNE SYSTEM eλCKGRCu:- OF τy.∑ ΓMVINTION 1. rield of che l.-.va-._ian The present in e ticr. provides novel prcphvlacti- --■-- therapeutic nutritive compositions that are useful in t he raa ar.d/or maintenance of a health-protective intestinal b cter al f" -= and simultaneous! _n the enhancement of the irr.rr.u~* «•-=-»-, V--._ specifically, the novel nutritional supplement compositions of trepresent invention scntain hsy protein concentrates :r isolates , fruc oclicosacchaπdes, an d hcvi e or caprir.e colostra-. 2. Background of the Invention It has recently been determined that a major compartment cf _:._ mammalian immune system is located in the digestive tract, and it = understood that the most intimate contact with the physical world is mediated through the iπgesticn of foods. [N. Wagner e a ., Nature. 332 (€533 ) :356-70 ( 199S ) ] . Consequently, by interacting with gut- associated lyrnphoid tissue, i gescants may affect the entire becv and overall health of the mammal. Therefore, a healthy digestive tract is important to the overall health of a mammal. The interaction Between icroflora and lyrnphoid tissue present in the gastrointestinal tract, and how their relationship affects overall health, is currently of great interest to the medical community. Certain groups of icroflora are known to produce toxins that have adverse health effects. Certain other bacteria, however, are understood to be advantageous inhabitants of the intestinal tract of mammals. Therefore, it is desirable to manipulate the ccmocsitior. of Gastrointestinal flora towards mσr a ne-e- 11 ' ---- bacterial species. Diet s known to influence ' bacterial species composition m the gastrointestinal tract. The maintenance or enhancement c: beneficial icroflcra may be accomplished in two principal ways. First, -cne may s-imp y ingest beneficial exogenous bacteria, called "prcbiotics, " in order to incorporate them into the gastrointestinal milieu. The other alternative is to ingest substances, called "prebiotios, " that are known tc support the growth of b e cial bacteria already present in the gastrointestinal tract. Regardless of the method used to enhance beneficial bacterial flcra in the cut, the results cf doing so include improvement cf lactose absorption and tolerance, control cf intestinal in ectitr. a check on adverse overproliferation cf cells lining the gastrointestinal tract, anti-choiesterola ic effects. and improvement in gastrointestinal motiϋty. [S.Ξ. Gilla d, J. ;a__- ≤c_i__, 22:2433-94 (1989)] . 3y ingesting compounds that help enhan a the growth of beneficial bacteria, these effects may be achieved. Such beneficial bacteria include lactobacilli, which are understood to produce antibiotic- like substances that inhibit gram-positive infection, inhibit other disease causing bacteria such as Shi gsils sonr.ei , and may possess anti-overproliferatiσn and ar.ti- cholesterole ic effects. Another beneficial bacteria is Bifidcbacteria, which s understood to have suppreβsivβ effects on disease -causing Eschsrichia cell and Clos criiiutπ perfrir.ger.s . Bi idcbacteria also produce acetic acid and lactic acid which lowers intestinal ?K and inhibits the growth of other deleterious bacteria, and may be involved in preven t ing the overproliferaticn of cells in the colon. r n . Gallagher et a . , .T ■ N tr... 12_L: 13S2-71 ( _ 9 .6 ) ] . In addition . 3ifidcbac t eria t irnulace. the production of 3 it m ns, s ch *- vitamin B ;:, that are often deficient in pecpie suffer i ng ::: " gas t ric disorders or inadequate ingesticn cf vitamin 3.. : due t = ve g e t arianism or peer diet. Whey is the curd- free portion of milk that is left over fr ~ . the production of cheese -- a by-product in the form cf ar. amalgama t icn of low molecular weight proteins that remains a ter t he casein fraction is removed with the curd , O more than about twenty years ago, whey protein was still little more than a was t e by ¬ product to the dairy industry, the only use of wh i ch was as animal feed by a handful of innovative cattle ranchers. Seme dairy __ . _ . m«- alsc understood that whey was a good source of low-fat protein , not only fer animals, but also for humans. τ n recent years, however, science has finally caugh t up vi-. traditional wisdom and discovered the many health benefits of wh y or=t ein. With the advent of modem food technology, whey prote i n has been concerted and refined into whey pro t ein concen t rate ( WPCΪ, containing 30-85* protein, and whey protein i solate ( WPI-, containing 90% or more of extremely low-fat whey protein. Athletes were among the first people to apprec i ate these ne ^ 3 l ow-fat protein sources - nearly fat-free whey protein concentra t e and isolates helped athletes gain lean muscle mass, while simultaneously providing a sca ce of energy for strenuous sports activities. " However, athletes are not the only ones to benefi t from whey protein. A high percentage of AI3S and cancer tatients are su ferine from chrcnic diarrhea and maiabscrption of utrients. They are in Ganger or succ mnmg to tne terricie wasting sv-_: !cac s>-ia) that is all too often the actual cause of death. 2- sut ' r. cases, FC or WPI can often stop the diarrhea, help them gam weight, and help prolong life. [G. Bcusncus et al., Clinical _ -r_y.a.s__.isative ed. , .(3) -.204-209 (June 1993)] . Similarly, many _f the elderly are malnourished and underweight due to a tendency to have little appetite, poor diet, and digestive problems. Hence, the elderly also benefit from food supplements like WPC or wp: that d. nct burden weakened digestive systems with food products that contain hard-to-digest fats and oils, or empty sugar calories, as in seme nu t ritional drinks, foisted on them by intensive advertising, On the other hand, WPC or WPI can also be used to lose weight, if combined with a low-calorie diet. It can even be used to replace a meal, as for instance, with professional people who ingest a whey protein drink in the office, instead of going out fcr lunch. Aside from the purely nutritional properties and effects cf whey protein, including weight control (gaining or losing weight: , i t is now understood that WPC and WPI are able to enhance the immune system due to the presence cf certain "whey protein fractions," including serum albumin and ' the immunoglobulins which have immunomodul ing effects- Immunomodula ing effects refer to those ac t ions that keep the immune system at homeostasi activating nor suppressing it beyond that which is beneficial tc the body as a whole. There are four categories of protein fractions i whey pro t ein. Those skilled in the art understand that so-callsd " a^or" protein factors of whey protein concentrates or isolates are, in crder or prevalrenfee , -2-lactogiobuiin ( S-Lg ) , i - acca bvr r. l a-la ) , bovine serum albumin ∑S ) , and the immunogiob i s in zr.a . z Λ - β '-v '-nciudinσ all five classes) , each cf which is known to be an impor t ant part of the immune system. [C.7. crr and £.γ. Ha , C ri t . ?. £ ' /■ in rood Sci . and S cr.. __3 (β) « 21 -475 ( 1533 " ;. W PC and WPI also contain a number of so-called "minor" w.-.ey crotein factors that may have important non-nutritional propert i es. CC.V. Mcrr and E.Y. Ha, cited above ; P.F. Fox , ^ w r .mi- - . Fox, P.F., ed., Elsevier Applied Science, New Y:r . < ( 1989 ) ; • These "minor" whey protein factors include lactcferr i n. lactop h orin, lac t o-peroxidase, and lysozyme, wh i ch are also understood to have antibacterial and other biological func ti ons. [3. Reiter, *- * - -<""■« *«" - 1:8 7 ( 1983 ) ; 3. P.e i t.r. - ^ ,_.^,_.-_ r n^> rh^_._rv. 281, Fox, P.P., t . . Elsev i er Aoplied Science, New York (1285); C. Kanne, J , ^^ Sc, IS , -- ( 1389 ) 1- Whey proteins are a collection of different types =£ pro t eins - eacϊ^f which has a lower molecular weight than those m the casein fraction'removed during cheese processing. Whey pro t e i ns include many prote i ns that have been characterized ( such as . he- identified above ) as well as numerous others whose physiological function, are not yet fully understood. For example, as ment i oned above, the known proteins in whey protein include lysozyme ar.c iacto-peroxidase, each cf which are known to have important antibacterial functions. actoferrin is an iron-binding glyccprctsir. that has broad antimicrobial properties and may have immunomcdulatory effects as well. One aspect of the antimicrobial effect of lactoferrin stems from its ability to chelsta iron rt-. pathogenic bacteria, thereby preventing their propagation. There = fur t her evidence that, in addition to its iron-binding capacity, certain structural domains in lactoferrin pcssess a bread range ;: antimicrobial properties. [ . Tcmita et ai . , Adv. Ext. y*-± . -i l.. 357 :20S-13 (1994)]. Although it is understood that lactoferrin exer t s a bactaricstatic effect on beneficial and pathcgsπit bacteria, it has recently been shown that harmful bacteria, such is E . C U , are more susceptible to lactoferrin' s bactericstatic effect than Bifidobacteria. (W. Bellamy et al., . AOPI . 3actericl. 71": 472-79 (1992)] . Aside from the "major" and "minor" proteins, WPC also contain- a variety of beneficial nutritional components, including ash. ncnprσtein N compounds (nitrogen-containing compounds ) , iipids. lactose, phosphoϋpids, as well as trace amounts cf scdiur .. potassium, calcium> magnesium, and phosphorus . tC.V. Mcrr, and S.A. Fcegeding, rond-Technol-. - 44:100 (1990)]. Nonp otein N compounds i nclude products of protein catabolis that are ultimately conver t ed to urea and excreted, such as blood urea nitrogen ( BUN ) - - the form. of urea that is transported through the bloodstream to the k i dney for excretion. Thus, whey protein contains a host of proteinacecus components and other constituents, including vitamins and minerals , that are known to be of critical nutritional importance in human* and animals. Whey protein is also a concentrated scurce cf amino acids that are known to effect glutathione levels. _ Glutathione is a sulfur-containing tripeptide (r-clu-cys -=!■-* that is pivotal in cellular protection against oxygen radicals an t a wide spectrum cf xenobictits, and that helps maintain cellular proteins in a functional stats. Glutathione s also involved ir. lyr.phocyte . proliferation . It is extremely difficult t -*- 0 glutathione -- a first-class free radical scavenger and detoxifi r - - into immune system cells and body tissue. Yet, accomplishing this is vital, because our immune system cells, such as lymphocytes. natural killer (NX; cells, and macrophages, depend on glutathione it accomplish their toxin surveillance and detoxi ication 'tc Ξ effectively. Glutathione is synthesized in a series of enzymat t steps -- the rate limiting step involving r-giutamyl cyste ne syr.thetase and intracellular cysteine as the rate limiting substrate. Since concentrated whey protein is a good source of cysteine, cystine and other peptides and amino acids that ars : related to glutathione synthesis, it is believed that cysteine. cys t ine, and the other nutrients in whey protein are involved i mediating t he immune response through modulation of glutathione levels by fostering glutathione ' synthesis . [G. Bounous, et ai . , Clin. and Investicati - Med., 12.(3 ): 154-161 ( 1989 ) ]. S FOS are a fiber-like, indigestible type of sugar, present in a variety of plants (e.g., onions, asparagus, Jerusalem artichokes and S wheat) , from which they can be industrially extracted by enzyma t it fermentation. Commercially available FOS is therefore a whollv natural product. The impact cf FOS en intestinal icrcflora has beer, extensively studied. In vi tro studies with isolated bacteria have demonstrated that FCS are good substrates for the 3i dcbacteria sec -- one of the beneficial species of microflcra. [ . Ckada, et al . , Second eosuσar Research Conference, Tekv. I _ 72 - I i • ~CS are short- and medium- length chains cf 3-2 f uecans in which fructosyl units are bound by a 3 2-1 glyccsidic linkage, Cecending on chain length, as defined by the number cf osyi units (called the degree of polymerization) , FOS are named ciigof ucccse cr ir.ulin, the latter having a higher degree cf polymerization. 2 = are prebictics since they selectively encourage the growth t: advantageous gastrointestinal bacteria, such as 3ιfidcbacteria . According to current nutritional knowledge, colostrum represen s a unique combination of beneficial nutrients, including car - ro ydrate, fat, and amino acids. Colostrum also contains natural v i tamins ana minerals, which, although not abundant in qu ntit , ars - h i hly bioavailable. At a minimum, the presence of even a rela t ively small amount of colostrum, as present in the compositions cf the present invention described below, can therefor* be expects-. to provide considerable nutritional enrichment. Colostrum, however, has many health-promoting properties beyond and apart from its purely nutritional ones. For instance, it also supplies the neoπate with several types of growth- romoting factors such as epidermal growth factor that induces synthesis of epidermal cells, transforming growth factor that induces collac.n synthesis. wound healing and bone-resorption, and insulin-like crow t h fac t or (IGF-1 ) which induces epithelial cell proliferation a d is nscessarv 5 for growth and repair of healthy tissue. [C.Ξ. Grosvencr, et a ., -Sr.dccrir.e Reviews, i (.≤ ) s 710-723 (1992s); G. Carpenter, Scier. t s. 210:193 (1930); D.A. Cox, and .R. Buerk, Fur. ' . 5i_g«^ 1 7 -.3 ; ; - 58 (1991); and P. G. Campbell, and C.R. Baumrucker, __. ϊndocrinc 12.._.: 21-25 (19-9)]. These effects of the various growth factors 0 whether originating from bovine, caprine or human breast milk, seem to be non-species specific and can hence be assumed to apply :: humans. [S.M. Seyedin et al . , J. Biol . Che .. _£l'. * -3) :5S93-9_ (1936)] . Recent research also indicates that the growth factors in colostrum tend to survive the environment of the gut and can thus bs S expected to exert their important functions in both neonates and adults. [C.E, Grosvenor et al . , cited above]. Colostrum also contains proline-rich protein (PR?- that induces growth and differentiation of resting B lymphocytes, which is integral in the development of immune response. 3 lymphocytes are 2 referred to as "resting" during their inactive phase , i.e., while not responding to ' stimulation by an antigen. In addition, ?R? is understood to aid in the maturation of thymocytes, originating from the thy us -- a crucial organ for the early development of the immune system. PR? is further understood to aid in the generation 5 of T-suppressor arid T-helper cells, demonstrating that it can have either a stimulating or suppressing effect on immune response. [ . Starcscik et al . , i πmu r.ol.. 22.(12) : 1277-32 ( 15S3 ) ] . Colostrum is further understood to contain a chr mium-biπdinc substance with properties similar to those cf glucose toleranc * factor -;GTF) -- a trivaient chromium compound naturally cccurriπc J - Brewer's yeast that is understood to improve glucose tolerance and act with insulin m promoting normal glucose utilization . Se.sr.ium s a t race, lemen essential to normal metabcl t functions. The level of daily selenium intake , either ≥v supplementation or m certain foods, should be between about ΞC __- and about 200 μ g. Some of the suggested functions of selen i um i < - - " -a body include immune system stimulation, detoxification of percxiάized fats and heavy metals, anti-inflammatory properties , and an -proliferation properties. Extremely high doses cf selen i -m however, may have the opposite effec t and cause t e cverproliferaticn of cells. Selenium is understood to play a role in glutathione peroxidase activity. The glutathione peroxidase enzyme, a potent ar. ioxidar.t , is _ made up of four identical subunits, each contain i ng selenocysteine in its primary structure. Hence, the presence t selenium is required for the proper functioning cf glutathione peroxidase to oxidize free radicals, such as hydrogen peroxide . [M.S. Shils, et al . , , Modern Nutrition in Health & Disease , 1:242-2 = : ( 1994 ) ]. Selenium is known to be involved in the metabolism c: thyroid hormones that are involved in the immune response. _:- 3. Description of Prior Art Because of the above-described properties, WPC/WP1 is widely u se d as a functional and nutritional ingredient in medical , ph armaceu t ical, and human food products, e.g., infant formula , he a l t h feed s and drinks, and frozen foods , [ λr.or.r, Am. Dairy ?rcd. Ir . s t, , C hicago (1992)] . In addition, the use of whey protein as a _ sour ce cf bi olog ically active components such as α-La, S- g , 3≤.-.. immuncgio b uiins , iactoferrir., and iacto ercx dase has beer , incre as ingly recognised. !=. Korton et al., J. , ... Ttetarv S c . ( 19 95)]. Unfcrtunateiy, certain whe y ocessi g tec h n i ques whi c h have been used in the past and w hich are s t ill 3 extensively used m the focd industry ( such as certain kinds t : pas t eur i za t ion, aeration, vacuum evaporation, and spray dr y in g) oa. c a u se vari o u s le v els cf denaturaticn of delicate serum al bum i ns , imunoglobulins, an d other whey protein factors , thereb y e f f e c ti ng th eir immun -enhancing capabilities. Although this re s ul t s i ,3 pro d u c ts that r e main a good source of ncn- πteat p r ote in , th es e produc t s are no t likely to strongly enhance the i mmune sys t em. H o wev e r, e v en p a r t ially d enatured whey prctein may provide a cer t ain de gr ee of i m m un e - enh an c ement , as evidenced by increased l on g e v i t y i n an a nimal model. [ D. F . Birt et al., &,., Suςr . , 11 1 :2131 - 50 (1932 ; . 2 PC S are known to serve as substrate ( i.e. , food ) : t r 3i i dcbac te ria t hat make up part of the int e s ti nal micrc f lcr a . [ M. S . A iles ewal,, PΠ r , ,τ. ttucr.. 26:211-22 1 (1396); F- R .- * . Bcrne t , a m. . T. e l i n. N u t r_, ϋ(suppl) 7635-9S (1 9 9 4 ); F . Br i e t e t a l. , ffι ^--p . . Cl i n . W utr., i£:5Ql-507 ( 1995 )] . F OS have also b een 25 shown to hav e a decided bifidogenic effec t ( i . e. , having th e beneficial effec t s of Bifidobacteria) in physiologica l sys t ems li k e the human body. [H. Kidaka et al . , Bifidobactsria wjcrcflora. 5:3?- 50 (1986 ) ; H. W. Mcdler et al., cited above], FOS have also been shewn to reduce the occurrence of colon tumors and conccmi anr.lv developed cut -associated lyrnphoid tissue in mica, there v counteracting the advanced stages of cclcn carcinogsnesis . - . Pierre et * ' - - Carr*r ^ .. 12:225-28 (19.7)j. Proteins present in bovine or caprine colostrum are understood to indues growth and differentiation of resting 3 lymphocytes. [ . Julius et s ., J. Immunol ■ , 140 (5) : 1366-71 (1938)3. Colostrum s further understood tσ contain a protein that helps protect against infections of E . coli. [A. Ouwehand et al.. Infec ion and Immunity. £2.(12} :4917-20 (1995)] . Bovine or caprine colostrum may also help enhance resistance to Crγatospor±dium parw . [B. Wats! et al . , Am . J . Troo . Med . Hvσ .. £8 (4) : S19-23 (19-93)]. 3 AS stated above, selenium is known to play a role in glu t athione peroxidase activity. Selenium appears to affect glutathione' s anticxidant activity by contributing to the maintenance of the ucosal barrier in the gut. CM.G. O'Riorda et al- , Nutrition. i2(Suppl. 11-12) :S82-84 (1996) ; T.R.. Hayward et a . , . j. sure. Rss., _B.(4) :351-353 (1994)]. It has been shown that dietary selenium increases glutathione peroxidase activity, for example, by reducing susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. [ . H USS βin et a . , Tr S n S π1_nt-tian. £2,(5) :S79-685 (1997)]. The 5 benefits of proper levels of selenium in maintaining glutathicne peroxidase levels in infants, whether breast-fed or formula-fed, has been documented. [u. Trafikowska et al., Acts vm A * » r - 45.(10) : 1143-45 (1996)] . in addition, dietary supplementation w --- selenium has been shown to provide a protective effect in <-_.""- against peroxides. [Y. Kayanoki et al . , J. Sicchem.. ii9 ) : 2i?-;i" (1996)]. •Many people, especially AIDS patients, have been desceratelv - - - > trying anything from taking free cysteine to N-acetyl-cysteir._ (MAC) , or s drug OTZ to get glutathione into their depleted i π-. ne system cells. Such efforts have not bean entirely successful since these compounds can be toxic in inappropriate dosages and since thev do not always raise cellular glutathione levels anyway. [T. 3rav ar.aC. Taylor, Bioehem. Pharma . , 47 (12) ;2113 -23 (1994)-. Therefore, it would be extremely advantageous to be able to raise intracellular and tissue levels of glutathione by nutritional means. This is but one function of the nutritive eβmpositions of the present invention described in detail below. There remains a need in the art for nutritive supplements that con t ain ingredients that ara sufficiently biσavailsble to help maintain and enhance beneficial gastrointestinal micrcflora, that function as a source of low-fat protein for use in building muscle and gaining weight, .or alternatively, for losing weight when ingested in conjunction with a low calorie and low- fat diet, t ha t function as a source of growth factors for the repair and growth cf healthy tissue, that enhance the immune system, and that enhance glutathione levels. SUMMARY Or THE INVENTION The -present invention overcomes the shortcomings of the pric_- art by providing nutritive supplement compositions that contain a novel combination of whey protein, FOS, and colostrum. Moreover, each o these ingredients is provided in a form that is bioavailsble and may thus _accemplj.≤h their important nutritive and immune - enhancing functions. It is therefore an object of the present invention to provide nutritive supplement compositions comprising whey protein, FOS a t colostrum, It is a further object of the present invention to provide methods of using such nutritive compositions to protect, enhance, and maintain health-protective microflora in the intestinal tract cf mammals . It is still another object of the present invention to provide nutritive supplement compositions that are a source of low- fat protein that humans and mammals use to help build muscle and gain weight . It is yet a further object of the present invention to provide nutritive supplement compositions that are source of low-fat protein that, when ingested in conjunction with a low calorie and low-fat diet, may help , *rumans and mammals lose weight. It is still another object of the present invention to provide nutritive supplement compositions that are a source of growt factors for the repair and growth of healthy tissue. It is a further object of the present invention to provide methods cf administering the nutritive compositions c the present invention. It is another object of the present invention to enhance the immune system of humans and mammals through the administration tf Ξ such nutritive supplement compositions. It is yet an additional object of the present invention to provide nutritive supplement compositions that enhance the levels of glutathione in human and mammalian cells and tissues. It is still another object of the present invention to add 3 optional ingredients, such as selenium, to the nutritive compositions cf the present invention. Various vitamins and minerals, s disclosed in the detailed description c£ the present invention, may also optionally be added to the nutritive compositions of the present invention. S These and other objects of the present invention will be further described in the detailed description section that follows. DETAILED DESCRIPTION OF THE INVENTION The nutritive compositions of the present invention are a novel combination of whey protein concentrate (WPC) and/or whey protein : isolate (WPI) , fru ' ctooligosaccharides (FOS) , and bovine or caprine colostrum. These* ingredients in combination have a prophylactic and therapeutic effect in maintaining and enhancing beneficial gastrointestinal microflora. A healthy intestinal environment will enhance the overall health of the mammal since many diseases, no 5 matter in what part of the body they manifest themselves, actually i o start in the gastrointestinal tract. In addition, as described above, the nutritive supplement compositions of the cresen t invention contain ingredients in a form that is bipav liable and rr.sy thus accomplish heir important nutritive and immune-enhancing functions. The nutritive compositions of the present invention also function as a_9curce o-f low- at protein that humans and other mammals can use to help build muscle and -gain weight, tr alternatively, when ingested in conjunction with a lew calorie ar.i low- at diet, may help humans and other mammals loss weight - "-"-_ nutritive compositions cf the present invention further function as a source of growth factors for the repair and growth of healthy tissue, Moreover, these compositions are understood to contain components that enhance the immune system of humans and mammals, and enhance the levels of glutathione, a ubi ύitous intracellul≥r antioxidant, in human and mammalian cells and tissues. The nutritive compositions of the present invention benefit humans and animals by helping prevent afflictions that may arise from unhealthy gastrointestinal microflora. In other words, by promoting , healthy bacteria in the gastrointestinal tract, the nutritive compositions of the present invention prevent the proliferation of ' unhealthy bacteria, thereby preventing t e i r harmful effects: -, In addition/ for humans and animals already suffering from an unhealthy balance Of gastrointestinal bacteria, the nu t ritive compositions of the present invention may help ameliorate such conditions by promoting the growth of beneficial bacteria. Moreover, the compositions of the present mva-tion may hs'c combat malnutrition in humans, whether due to illness or becaus * basic " foodstuffs are unavailable in certain undarerivileced populations. Malnutrition and the resultant immunodeficiency placue many third world countries. These conditions are the leading cause of infant and child mortality, and .play a significant role r . disease m the general " population and in premature death in t hs elderly. I particularly severe instances, there is a deficisr.cv t_ ail nutrients called marasmus. More often, the deficiency is primarily one of insufficient protein intake, leading to the conditions cf kwashicrkor or protein-energy malnutrition (?ΞM' . Such deficiencies are often coupled to vitamin and mineral deficiencies. These kinds of nutritional deficiencies are by no means limited to third world countries -- even industrialised nations have population segments that suffer from malnutrition of one form or another. Malnutrition also affects persons suffering from AlϋS, certain forms of cancers, and infectious and inflammatory conditions of the gastrointestinal tract, particularly the intestine (e.g., irritable bcwel syndrome, Chrone's disease, and chronic gastroenteritis! . In such cases, malnutrition is typically not the result cf inadequate ' food intake, .rather from the inability to absorb foods and derive nutritional benefit. Hence, it is desirable to provide nutritive compositions that have the dual effect of providing sustenance as well as helping to improve the intestinal microflcra and enhance the immune system. The nutritive compositions of the present invention contain substan t ial quantities of proteins to supplement the human diet. In addition, the present compositions, when optional vitamins and minerals are added as described below, may contain from about 30% to about 500% of the Recommended Daily Allowance ( RDA ) or Daily Value ( DV ) of vitamins and .minerals, as established by the National Academy cf Science. Moreover, the compositions cf the present invention , as more fully described below, help enhance the i m e system. As described in the above background section, whey may be ir. the form cf powdered whey protein, or concentrated i whey pro t ein concentra t e ( WPC ) cr whe ' y protein isolate ( WPI ) , t he lat t er being the most concentrated form. Whey protein is understood t o be useful in providing a low- fat energy source that is useful in weight con t rol, and further is known to enhance the immune system 5 principally through whey protein f actions. The major proteins in PC/WPI (S-lactoglobulin, α-lactaibumir. , Immunoglobulins , and bovine serum albumin ) are known to have immuπc cdulating effects. Moreover, bovine serum albumin. 3- lactoglobulin, and immuhcglabulin G ( IgG ) each contain glut ylcystaine groups -- building blocks from which immune system cells can synthesize the key antioxidant, glutathione. Glutathione, as described above, is understood to be responsible for the immune- enhancing effect cf undenatured whey protein previously described 25 above. Therefore, whey proteins, and preferably WPC and WPX, are an ideal and convenient food supplement for both gaining cr losing weight, dependent only on the rest cf the diet. In addition, W?C cr WPI, particularly when combined with FOS and bovine or caprine colostrum as in the present invention, promotes gastrointestinal health. Finally, W?C or WPI, if in a relatively undenatured state, are aisle to promote the ϊntracellular synthesis of physiologically effective levels of the anticxidant glutathione. Mere specifically, the immune-enhancing effect cf whey protein acrears t o derive from its ability to function, under certain favorable conditions (relative degree of ncn-denaturation ) as a vehicle for the transport of cysteine/cystine, glutamine, and ether amino acid precursors for protein synthesis. As one example, the ΠO Ϊ I- ssential amino acids cysteine/cystine contained in concentrated whey protein are utilized by immune system cells ( e.g. , lymphocytes to synthesize the antioxidant tripeptide glutathione. In other words, it appears that enhancement of glutathione levels in the tissues from a diet of whey protein may be the underlying . immune factor t o have produced a number of observable immune-enhancing effects in laboratory studies with rodents, e.g. , life-extension and increased resistance to carcinogens and to certain infections , as described abov . For inelu^isn in the nutritive compositions of the presen t invention, it is preferred to use WPC and WPI in their puri ied and undenatured form. However, even partially denatured whey protein provides a certain degree of immune-enhancement . One of the more recent and favorable processing techniques for obtaining substantially undenatured whey proteins s via cross -flew icrofiltration technology ( CFM ) applied by Avcnmore g edients. Inc. This technique utilizes a porcelain membrane tc filter and separate denatured rom undenatured small molecular weight croteir.s . -. This creates a filtrate that is highly (over 98%) undenatured. Predecessor techniques of-membrane filtration involved a fiitra t i t n process that could itself damage proteins as they pass through the membrane. Porcelain membranes, however, are less reactive to intact small molecular . eight proteins during the course of filtration and : thereby reduce potential injury to . undenatured proteins while separating those that have been denatured during procassing. Since serum and tissue glutathione levels are knowr. to decrease in degenerative diseases of aging and since many diseases are further understood to be related in part to depleted glutathione = levels, the ingestion of WPC or WPI via the compositions of the present invention can reasonably be expected to increase giutaπhicns levels in the elderly, in persons with cancer and/or pcst- che otherapy or radiation therapy patients, in HIV sero-positivs persons, in people with certain degenerative CNS conditions, such as . Alzheimer's and Parkinson's disease, and in persons suffering from other degenerative conditions that are thought to be at least partially frees • radical-driven and characterized by depleted glutathione levels. Still another group that might benefit from the immune-enhancing effects of WPC or WPI, as included in the 3 compositions of the invention, are athletes or others engaged in strenuous physical exercise. In a preferred embodiment, the whey protein used in the compositions of the present invention are undenatured or substantially undenatured, similar to that of raw, unpasteurized milk- However, as stated above, partially denatured whey prote i n ill retain some of its immunelogical function, and hence is s t ill useful " althougrfnc t preferred. Commercially available whey pro t e i n concentrates and isolates vary greatly as to processing temperatures and t echniques, resulting in raatar or lesser relative degrees t : denaturation. Commercially available forms of whey protein, wpc and WPI that are subs t antially undenatured include but are e t lim it ed t o Proven 1 9 0 and wpc 80% {Avcnmore Ingredients , Inc.]. The amount cf whey protein, WPC or WPI that may be used in t he compositions of the present invention will depend upon hew concentra t ed a form of whey protein is used, and the route cf administration. However, it is intended that one dosage of t he compositions of the present invention (whether in liquid or solid form ) . whey protein, WPC or WPI may be present in the amount from a b out 0.01 g to a b out 100 g per dosage for humans and small animals. and from about 0.01 g to about 1 kg per dosage for large animals . FOS are a fiber- like, indigestible type of sugar -- short- and medium-length chains cf β-0 fructans in which fructcsyi units are bound by a β 2-l gl « yposidic linkage -- that are present in a varie t y f plants ( e.g., onions, asparagus, Jerusalem artichokes and wheat ) . from which they can be industrially extracted by enzymatic fermentation. Commercially available FOS is therefore a wholly S 3 natural product. FOS is commercially available in the form of bulk pcwdar [Nutra lcra. Golden Technologies Company, Inc.]. I; is intended that one dosage cf the compositions of the present invention (whether in solid cr liquid form) will eontain from about C.01 g o about SO g of FOS per dosage for humans and small animals, and from about 0.01 g to about 500 g per dosage for large animals. The other Ingredient in the nutritive compositions c: the present invention is colostrum -- the "pre ilk" cf laccatir.s mammals. Ξcvine and/or caprine- colostrum, are particularly useful forms of colostrum for purposes of the present invention. Colostrum represents a unique combination of beneficial nutrients, including carbohydrate, fat, and amino acids. Colostrum also contains natural vitamins and minerals, which, although not abundant in quantity, are highly bicavailable. The health benefits of colostrum include the provision tf several types of growth-promoting factors such as epidermal growth factor, transforming growth factors, insulin- like growth factor , proline-rich protein (PRP) , and a chromium-binding sucstance with properties similar to those of glucose tolerance factor. Oligosaccharides, naturally present in colostrum :as distinct from FCS) , may prevent attachment " of pathogenic bacteria ( e.g., of pneumococci) to, .epithelial cells, and do so as specifically as antibodies. Thus, by preventing the attachment of pathcgenic micro ¬ organisms to the intestinal mucosa, these oligosaccharides fulfill a similar function to FOS (that fosters the growth cf beneficial bacteria such as lactobacilli and Bifidobacteria ) and help maintain healthy gastrointestinal microflora. In a preferred form, the bovine or caprine colostrum is sprav- dried, organic bcvir.β or caprine colostrum. Such bovi-e cr cacrins colostrum is commercially available [Sterling Technology, Inc . j , It is intended that one dosage of the compositions c: the present invention (whether n solid cr liquid form ) will contain from about 0.-1 g tc about 100 g of bovine or caprine colostrum per dosage in humans and small animals, and from about 0.31 g to about l kg ar dosage in large animals. However, there is no known point t: diminishing returns as far as the amount of colostrum that may zz ingested is concerned. To ' '& contrary, fcr therapeutic purposes, such as to fight infection or chronic diarrhea, the mere colostrum the better. Selenium may optionally be added to the compositions ef t s present invention. As described above, selenium is understood t_ play a role in glutathione peroxidase levels as well as provide immuno- nhancing functions. Preferred forms of selenium for use m the nutritive compositions of the present invention are organic forms of selenium, particularly selenium amino acid chelate. Th s form of selenium is commercially available [Wright in ϊlichmcr.d . Inc., Lafayette, Louisiana; or Watson Foods Company, Inc., Wes t. Haven, Connecticut] . When present, it is intended that one dosage of the compositions of the present invention (whether in solid or liquid form ) will contain from about 20- \ q to about 200 μg of selenium per dosage in humans and small animals, and from about 20 mg to about ISO mg per dosage in large animals. Thus " , the compositions cf the present invention include from about 0.01 g to about 100 g cf whey protein, about 0.21 g to about =0 g FOS, and about 0.01 c to about 100 g bovine er caprine colostrum per dosage. One daily dosage of the nutritive compcs-itions of- he present invention may be from about 10 g per day to about 250 g taken one to three times per day for humans and small animals, for a total daily ingestion of 10 g to 750 g depending on the needs of the recipient. For large animals, one daily dosage may be from about 100 g to about 1000 g taken one to three times par day, for .a total daily ingestion of about 100 g to about 30C g deoe ding on the needs of the recipient. In a preferred embodiment, a nutritive composition of the present invention comprises about : g of whey, FOS, and bovine or caprine colostrum per dosage. These preparations may be made by conventional methods. Tt prepare the compositions of the invention, the above-described whey protein, FOS, and bovine cr caprine colostrum components may be com b ined in one preparation as the active ingredient in intimate admixture with a suitable carrier according to conventicr.al compounding techniques. Suitable carriers may take a wide variety of forms depending upon the form of-,pr.eparation desired for administration, e.g. , oral , subli gual, nasal, or parentaral. In preparing the compositions in oral dosage form, any of the usual pharmaceutical media may be employed. For oral liquid preparations (e.g., suspensions, elixirs, and solutions ) , media containing water, oils, alcohols, lavoring agents , preservatives. coloring agents and the like may be used. Carriers such as starches, sugars, diluents, granulating agents, lubricants, binders. disin t egrating agents, and the like may be used to prepare oral solids ( e.g., powders, gelatin capsules, pills, and tablets L zenges and controlled " elease forms may also be used. If desiref. tablets may be sugar coated or enteric coated by standard tech iq es . Examples of additional inactive components whi t h prcvide for easier oral administration include but are not lim it ed to beeswax, lecithin, gelatin, purified water, and glycerin. Ir. addition, oral dosage formulations of the compositions may be added to foods and consumed. Although any foodstuffs may be appropriate carriers for the presently disclosed compositions, da i ry products such. a- » s „y„o„g„ur-.rt, frrrcσzz--.-i- vyo w α y u « r*t, » ice cream, cheeses, and mil / . are preferred. For parenteral products, the carrier will usually cempr i s- sterile water, although other ingredients may be included, e.g. , to aid solubility or for preservation purposes. Injectable suspens i ons .ay also be prepared, in which case appropriate liquid carriers. * sus ending agents , adjuvants, and the like may be employed. The nutritive supplement compositions of the present invention n ,^ 4i n αthe- ingredients .of nutritional benefit or may optionally co ain otne- «i 3 £BU that aid In pr 0 =«-in. or -tor.g- of the composition. , ---h o.tional ingr-dients incluc- maltodaxtrin. d-ttsoM. -ruecc. 5 canola ell, «m sy p solids, natural or artificial flavor- ' .: colors, guar gu_, refined cellulose; dioalcium phosphate. — caseinate, medium chain triglycerides, dipctassiu phosphate. magnesium oxide, lecithin, ascorbic acid, inositcl, c ' ncl ne bitartrats, vitamin E acetate, nicotinamide, calcium antothanate. ferrous fu arate, sine sul ate, pyridoxine hydrochio ide, riboflavin, t hiamine mononitrata, manganese sulfate, vitamin .- , caimitate. copper gluconate, fc ic acid, folate glutamate, bicttn. sodium olybdate, potassium iodide, chromium cicclina t s. ehy t onadicne , selenium amino acid chelate , vitamin 3 , S ΞA . cyanecσbalamin, lutamine, and beta-carotene. Additional ingredients known in the art to function as dietary supplements, including herbal compounds and foodstuffs, are intended to be wi t h i n the scope of the present invention. These optional ingred i ents are preferred in the oral dosage forms in particular, and mere particularly when the oral dosage form is a powder. The nutri t ive compositions of the present invention may involve the admix t ure of dried whey protein, FOS, and bovine or caprine colostrum, each in powdered form. Alternatively, whey prcta n cc ti e β nera t e or isola t e, FOS, and bovine or caprir.e colos t rum contained in separate containers may be combined by the user. However, regardless of the form of administration, it is i mportant that a whey protein concentrate or isolate that has been carefully recessed in stfch- fashion as to avoid denatura icn be used. A * p ed above, a large percentage of commercially processed whey scat protein concentrate and isolate on the market has been largely denatured because of processing- conditions . Unless a denatured form of whey protein is used, the compositions of the present inven icn will have mainly nutritional value and will not be as valuable m immune system enhancement. In an alternate embodiment, the whey protein, FCS, and bovine or caprine colostrum ingredients may be admixed in a liquid (e.g., water) and ingested. Suitable liquids into which the powdered form , of t he " compositions of" he invention may be diluted include water, milk, soy milk, or fruit juice. W n in such form, the compositions of the present invention are preferably diluted into about 3 cs. ;f liquid per ' dosage . When in such form, it is preferred that at least 10 g of compositions of the present invention per dcsage is used, Fcr normal purposes, including the use of whey protein as a meal substitute in order to lose weight, one such drink ( containing i: ■ = of the compositions of the present invention) per day is sufficient. On the other hand, if the user intends to use the liquid preparation to gain weight or for other therapeutic purposes, it is preferred that two drinks (each containing at least 10 g of the compositions of the present invention) per day are ingested along with a hic ' r. complex carbohydrate diet. The following examples illustrate the preferred embodiments t= the present invention. These examples are illustrative cnly, and it net purport to limit. the invention in any fashion. SXAMPLE 1 A preferred composition cf the present invention for use ir. humans and small animals may comprise the following ingredients: Ijr-σradier.t pun whey protein °' 01 S ' FOS 0.01 g - . bovine cr caprine colα.strum o.oi g - i ΞXA PLE 2 A preferred composition cf the present invention for use large animals may comprise the following ingredients: I gredien __^s__nt whey protein 0.01 g - lOGO σ FOS* 0-01 g - SCO " bovine or caprine colostrum 0.01 g - iooo'g ΞXAMPLE 3 A preferred composition of the present invention for use humans may comprise the ollowing ingredients : Ingredient Amount whey protein 0.01 g - 100 g FOS 0.01 g - SO g bovine or caprine colostrum 0 , 01 g - 100 g maltcdextrin 1 9 - 30 g dex t rose 1 3 " 3S 5 fructose 1 g - 30 g canola oil o.i g ■ o.S g corn syrup solids l g - 50 g natural flavors 0.001 μg - 1 mg artificial flavors O.oooi μg - l mg natural colors 0.0001 μg - 10 mg artificial colors 0.0001 μg - 5 mg guar gum o.αoi g - 10 g refined cellulose 0.01 g - 10 g dicalciu phosphate 0.5 g - 3 g sodium caseinate 0.01 g - 5 g medium chain triglycerides 0.1 g - 0.6 g * * dipotassium phosphate 0.1 g - 3 9_fc_ magnesium oxide o .01 g - 0.9 g lecithin 0.015 c - 0.6 g ascorbic acid 0,02 g - 0.3 σ inositcl 0.01 g - l g choiine bitartrate o.oi g - ι g vitamin E acetate 10 ru - 200 ru nicotinamide 0.0005 σ - 0.05 c alcium pantotnenate 0.01 g - 0.5 g " 0 c ferrous fu arate 0.002 c- - 0.3 g zinc sulfate 0.005 c - 0.06 g pyridσxine hydrochloride 0.001 c - 0.25 g riboflavin o.ooos g - 0.1 g 1 5 thiamine' mononitrate 0.0005 c - 0.1 g manganese sulfate 0.0005 i - 0.1 c vitamin A palmitate 2, soo : : * j - s,ooo copper giuconate 0.0005 c - o.oos 400 μg - 2.5 mg foiic acid 2 0 folate glutamate 400 μg - 0.002 g 100 μσ - 600 μg biotin sodium moiybdate 15 μg - ■ 5C0 μg potassium iodide 50 μg - > 500 μa chromium picolinate 25 μg - ■ 500 μg 10 μg ■ ■ 500 μg 25 phytonadione se l enium amino acid chelate 20 μg ■ ■ 200μg 200 Iϋ - 300 I vitamin D3 1 μg - 1000 μg PABA cyanocobalamin o.i μς - 1000 μg 3 0. glutamine 0 « ..-2 g 3 - 4- g, beta-carotene 5,0 00 _ U - 2 5, 0 0-: ΞXAMPLE 4 A preferred composi t ion of the present in v en tio n f or us* : humans and small animals may comprise the follow i ng in g re di en t s 35 " l0 ° 5 - SO g - 100 g - 8 g - 200 μg 40 SXAMPLi 5 A preferred composition cf the present invention for us in large animals may comprise the following ingredients: In g redient . Amount; whey pro t ein 0.01 g - 1000 g FOS .01 g - 500 g bovine cr caprine colostrum 0.01 σ - iooo σ glu t amine * 0-2 g - 25 g selenium amino acid chelate 20 μg - 150 mg Many modifications may be made without departing :rcm tne caste spirit of the present invention. Accordingly, it will be appreciated by those skilled in the art that the invention may be practiced other than has been specifically described herein.

Claims: Claims : l.. A nutritive composition for the creation and maintenance of a healthy intestinal flora and for the enhancement of the immune system comprising ; (a) whey; (b) selenium;. (c) colostrum. 2. The composition of claim 1 wherein said colostrum comprises bovine colostrum. 3. The composition of claim 1 wherein said colostrum comprises caprine colostrum. 4. The composition of claim 1 wherein said whey protein is in the amount of .01 gram to 100 grams; the amount of selenium is between .01 grams and 50 grams and the colostrum is in the amount of .0 1 gram and 100 grams. 5. A nutritive composition for the creation and maintenance of a healthy intestinal flora and for the enhancement of the immune system comprising: (a) whey protein concentrate; (b) selenium,- (c) colostrum; (d) glutamine; and (e) selenium amino acid chelate. 6. The composition of claim 5 wherein said colostrum is bovine colostrum. 7. The composition of claim 6 wherein said colostrum is caprine colostrum. 8. The composition of claim 5 wherein said colostrum is spray- ried. 9. The composition of claim 5 wherein said colostrum is organic colostrum.

Inventors: CRUM ALBERT B, ZIVKOVIC D DOROTHY, CRUM, ALBERT, B., ZIVKOVIC, D., DOROTHY
Applicants: CRUM ALBERT B, ZIVKOVIC D DOROTHY, CRUM, ALBERT, B., ZIVKOVIC, D., DOROTHY
Application year: 1999
Main classification: A61K35
IPC codes: A23C9, A23L1, A61K33, A61K35, A61K38, A61P3, A61P37, A61P43